Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05770037
Title DETERMINE Trial Treatment Arm 1: Alectinib in Adult, Teenage/Young Adults (TYA) and Paediatric Patients With ALK Positive Cancers (DETERMINE)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Cancer Research UK
Age Groups: child | adult | senior
Covered Countries GBR

Additional content available in CKB BOOST